cropper
update
National Cannabis Newswire
update
  • Home
  • Categories
    • news
    • trends
    • insights
    • industry
    • legalization
    • health
    • culture
    • advocacy
    • Brands
    • New Mexico Dispensaries
    • Arizona Dispensaries
2 Minutes Read

Melt-to-Make Patented Gummy Base Technology Supports Scalable Cannabis Edibles Manufacturing 

FOR IMMEDIATE RELEASE

Cannabis / Nutraceuticals / Manufacturing / Patent / Gummies / Growth / Scaling

“Our focus has been on removing unnecessary complexity from edible manufacturing,” said Sarah McLaughlin, MS, RD, co-founder and vice president at Melt-to-Make.

NORTHAMPTON, Mass. — February 20, 2026 — As the global cannabis edibles market continues to expand, manufacturers are facing growing pressure to deliver compliant, consistent, and scalable products. According to Fortune Business Insights, the cannabis edibles market is projected to exceed $55 billion by 2034, reflecting sustained double-digit compound annual growth.

The expanding market is increasing demand for manufacturing systems that reduce formulation variability while improving production efficiency. In response, many producers are adopting standardized formulation platforms to support reliable output across product lines, facilities, and geographic markets.

Melt-to-Make has introduced a patented gelatin and pectin gummy base technology designed to address persistent bottlenecks in large-batch edible production. The company’s shelf-stable semi-finished gummy base can be heated and infused with active ingredients before molding, helping manufacturers simplify workflows while improving repeatability.

By standardizing the gummy base, the Melt-to-Make system reduces common manufacturing challenges associated with traditional confectionery production, including inconsistent texture, lengthy research and development cycles, and batch failures during scale-up.

“Our focus has been on removing unnecessary complexity from edible manufacturing,” said Sarah McLaughlin, MS, RD, co-founder and vice president of product development and research at Melt-to-Make. “When the formulation system itself is consistent and repeatable, manufacturers can concentrate on dosing precision and operational efficiency rather than troubleshooting structure and texture.”

Traditional gummy production often requires specialized confectionery equipment and advanced formulation expertise, particularly when working with pectin in vegan and heat-stable applications. Melt-to-Make’s semi-finished gummy base is designed to integrate into existing production workflows, giving manufacturers a more standardized substrate for predictable results.

As regulated cannabis markets in the United States and Europe continue implementing stricter quality control and labeling standards, consistency in edible production is becoming increasingly important for both regulatory compliance and long-term brand reliability.

Standardized ingredient systems are emerging as a practical solution for achieving repeatable performance in expanding markets. Melt-to-Make currently serves clients in more than 15 countries and provides technical documentation, formulation tools, and production support for manufacturers implementing the technology.

To learn more, visit www.melt-to-make.com.

About Melt-to-Make™

Founded in 2018 in Northampton, Massachusetts, by Sarah McLaughlin, Jake Goodyear, and Tim Van Epps, Melt-to-Make™ specializes in innovative gummy base systems designed to simplify large-batch gummy manufacturing. By offering professionally formulated gelatin and pectin bases that are approximately 90% complete, the company helps manufacturers produce gummies faster, more efficiently, and with greater consistency.

Melt-to-Make™ is committed to using all-natural ingredients and colors while supporting a wide range of consumer preferences, including vegan, gluten-free, and non-GMO options. The company serves more than 1,000 B2B customers across the United States and in 15 countries, offering comprehensive support that includes equipment lists, training videos, custom formulations, and on-site technical assistance.

For more information, visit www.melt-to-make.com or call 1-800-241-0341.

Media Contact

Proven Media
Kim Prince
Phone: 480-221-7995
Email: kim@provenmedia.com

news culture Brands

53 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts

Discover Curaleaf’s CPD-Accredited Education Platform for UK Cannabis Prescribers

Update Curaleaf’s Groundbreaking CPD-Accredited Education Platform In a move to bridge the education gap surrounding medical cannabis, Curaleaf International has unveiled a free online platform tailored specifically for UK healthcare professionals. This initiative appears essential as the UK now boasts around 60,000 active medical cannabis patients, yet traditional medical education has barely scratched the surface of cannabis-related knowledge, particularly about the endocannabinoid system (ECS). Why Education is Key to Patient Access The absence of a structured learning framework surrounding cannabis treatment has left many healthcare providers in the dark. Despite its legality since 2018, widespread confidence among prescribers remains low due to insufficient training. Dr. Simon Erridge, Research Director at Curaleaf Clinic, states, “I regularly speak with GPs and consultants who want to have informed conversations with their patients about medical cannabis, but simply haven’t had the training.” A Comprehensive Curriculum Tackling Cannabis Education The newly launched Curaleaf Education Platform aims to fill this gap by presenting a comprehensive curriculum built on real-world data sourced from the UK Medical Cannabis Registry. This program focuses on three fundamental pillars: Foundational Science: Understanding phytocannabinoids and the ECS Core Clinical Knowledge: Covering formulations, safety, and management Advanced Modules: In-depth study on pain, neurology, and psychiatry Doctors and pharmacists who complete the courses can earn CPD accreditation that can be applied retroactively, offering even those with prior experience an opportunity to formalize their learning. Global Expansion on the Horizon According to Curaleaf, initial plans are underway to extend the education platform to international markets, fostering knowledgeable medical professionals globally. As education becomes a cornerstone of responsible access to cannabis, the potential for improved patient outcomes is significant. Elevating Prescriber Confidence and Patient Care Equipping healthcare professionals with evidence-based training can largely enhance their confidence in prescribing cannabis-based treatments. Juan Martinez, CEO of Curaleaf International, echoes this sentiment, stating, “Education is the foundation of responsible access.” This heightened confidence in prescribing practices could improve not only patient access to necessary treatments but also the overall effectiveness of medical cannabis as a therapeutic option. Moving Forward: A Call to Action The launch of Curaleaf's CPD-accredited education platform signals a critical advancement toward integrating cannabis knowledge into healthcare systems. It opens the door for a more informed medical community, ensuring that patients receive the guidance they need. For cannabis professionals, this is a pivotal moment to embrace these learning opportunities and foster a future where medical cannabis is recognized as a valuable component of patient care.

Explore Top Cannabis Strains for Summer Vibes and Adventures

Update The Best Cannabis Strains for Your Summer Adventures Summer brings with it long days, warm nights, and a sense of freedom and relaxation that many associate with outdoor activities and spending time with friends. But what’s a summer outing without the right cannabis strains to enhance that experience? As the cannabis industry continues to evolve, one thing remains clear: certain cannabis strains are perfectly suited for summer vibes, offering uplifting effects, refreshing flavors, and aromatic profiles that harmonize with the season. Why Certain Strains Shine Bright in the Summer Pleasingly, summer-friendly strains are crafted to evoke feelings of joy and relaxation. Many summer cannabis selections feature tropical flavor profiles and aromatic terpenes that invite users to unwind, making them the perfect choice for beach days, barbeques, or just lounging in the shade. Strains like Pineapple Express and Maui Wowie are not only pop culture references; they are also representations of the lively and invigorating nature of cannabis that's ideal for summer enjoyment. Noteworthy Strains to Consider When it comes to the top cannabis strains for summer, some enthusiasts have favorites that rise to the occasion. Headband, known for its relaxing effects paired with a creative boost, can enhance any outdoor gathering, while Lilac Diesel excites with its complex terpene profile that meshes well with summer activities, from hiking to casual socializing. Not to be forgotten, Bacio Gelato delivers not only a rich flavor but a euphoric high that can pair perfectly with a quiet evening under the stars. How Flavor Profiles Enhance Summer Enjoyment The tastes of summer can elevate the experience further. Think of sweet strawberries or tangy citrus; pairing these notes with your cannabis can enhance cocktails, enhance sunset viewing, or even make a barbecue better. Infused items, such as Kiva’s chocolate bars, add a luxurious touch to summer gatherings. S'mores with cannabis-infused chocolate are sure to be a favorite around the campfire! Considerations for Responsible Use As exciting as cannabis can be, it’s essential to remember the importance of responsible consumption. Each strain affects individuals differently based on personal tolerance and preferences. Explore moderation to enjoy the unique benefits these strains provide while being mindful of your own limits. Summer Cannabis: Embracing a Culture As the acceptance and legalization of cannabis continue to grow across various states, connecting this natural plant to summer experiences emphasizes a broader cultural shift. The joy of sharing cannabis with friends and family resonates with the sense of community and celebration that summer brings. With evolving regulations, podcasters and enthusiasts alike can explore ways to celebrate and advocate for cannabis within their networks. Discovering the best summer cannabis strains not only involves understanding their effects and flavors but also the culture that surrounds their use. Embrace this season of enjoyment responsibly and look for ways to incorporate these delightful strains into your summer plans.

Curaleaf Laboratories & HDB Unite to Transform UK Medical Cannabis Market

Update An Exciting Return: Curaleaf and Herdade das Barrocas Collaborate for Medical Cannabis in the UK In a significant move for the medical cannabis landscape, Curaleaf Laboratories and Herdade das Barrocas (HDB) have forged a strategic partnership aimed at reintroducing HDB's esteemed cannabis products to the UK market. This collaboration promises to enhance the spectrum of medicinal options available to healthcare professionals and patients alike. Elevating Quality Through Partnership Curaleaf, a prominent player in the UK’s medical cannabis sector, will leverage its MHRA-approved manufacturing capabilities to process cannabis flower grown by HDB in Portugal. This partnership is particularly exciting, as it combines HDB's established cultivation expertise with Curaleaf's rigorous quality assurance and distribution facilities. Richard Hodgson, Managing Director at Curaleaf Laboratories, expressed enthusiasm over the partnership, stating, “We are delighted to partner with Herdade das Barrocas and support the return of their products to the UK market.” This shared commitment to quality ensures patients receive only the best, while aiming to improve the overall supply chain resilience. Meeting Patient Needs with Innovative Solutions The strategic alliance between these two companies underscores their dedication to patient-centered approaches and innovative solutions. According to Telmo Costa, Director of Product, Markets & Operations at HDB, “The UK remains one of Europe’s most important medical cannabis markets.” With an increasing number of healthcare professionals recognizing the therapeutic potential of cannabis, the partnership stands poised to help fill the gap in accessibility and variety of medical options. The Future of Medical Cannabis Access in the UK This collaboration reflects the broader trend of strengthening the medical cannabis framework in the UK, where demand continues to escalate. With initial product availability targeted for June 2026, healthcare providers can anticipate an enriched portfolio that includes both previously recognized strains and new cultivars tailored to meet patient needs. As the UK seeks to establish itself as a leader in the medical cannabis industry, partnerships like this will be pivotal for overcoming barriers related to clinician education. In a recent initiative with The Medical Cannabis Clinicians Society, Curaleaf has already demonstrated its commitment to empowering healthcare professionals through education—an essential step toward ensuring effective integration of cannabis into patient care. Why This Matters to Cannabis Professionals For cannabis professionals, this partnership signifies a deepening commitment to pharmaceutical quality and patient-centered innovation in the rapidly evolving healthcare landscape. As access remains a challenge for many patients, understanding the implications of these developments will not only enhance engagement with the product offerings but also encourage broader advocacy for the integration of cannabis into mainstream medicine. Curaleaf’s proactive measures enable executives and stakeholders in the cannabis sector to anticipate changes in treatment protocols and cultivate stronger connections with both clinicians and patients who are increasingly turning to cannabis for therapeutic relief. Engaging a Growing Community The future of medical cannabis in the UK is on the cusp of transformation, and this partnership exemplifies a hopeful shift that could enhance treatment accessibility for countless patients. As Curaleaf continues to build strategic alignments, their efforts reflect the necessity for collaborative approaches within the industry that prioritize quality, reliability, and patient care. The call for a patient-centered cannabis framework is louder than ever, impacting not just those directly engaged in cultivation and distribution but a wider community of advocates who support the patients who rely on these products for their health. As we move toward June 2026, Curaleaf and HDB’s collaboration may very well serve as a model for how strategic partnerships can catalyze growth and drive quality within this evolving market.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*